Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Sulfinalol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.64 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 3/20 | 0.64 |
| ▸ | HTR1A | P08908 | 2/20 | 0.64 |
| ▸ | ADRB2 | P07550 | 16/20 | 0.55 |
| ▸ | ADRB1 | P08588 | 9/20 | 0.55 |
| ▸ | ADRB3 | P13945 | 7/20 | 0.55 |
| ▸ | DRD2 | P14416 | 2/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.55 |
| ▸ | DRD3 | P35462 | 2/20 | 0.55 |
| ▸ | PGR | P06401 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfinalol SCHEMBL6510272 | 0.98 | SLC6A4 (0.66) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| Sulfinalol SCHEMBL78008 | 0.98 | SLC6A4 (0.66) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| Sulfinalol SCHEMBL29387627 | 0.98 | SLC6A4 (0.66) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| Sulfinalol SCHEMBL121669 | 0.97 | ADRA1A (0.65) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| Sulfinalol SCHEMBL29918144 | 0.97 | ADRA1A (0.65) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| SCHEMBL9548061 | 0.88 | SLC6A4 (0.58) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| SCHEMBL11193698 | 0.87 | SLC6A4 (0.53) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| SCHEMBL11153294 | 0.86 | ADRB2 (0.64) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| SCHEMBL11371503 | 0.83 | SLC6A4 (0.48) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 | |
| SCHEMBL11156039 | 0.82 | ADRB3 (0.67) | SLC6A4ADRA1AHTR1ASLC6A2ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |